Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miranda N Hurst

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|September 15, 2016
Two-Dimensional Fluorescence Difference Spectroscopy to Characterize Nanoparticles and their InteractionsMiranda N Hurst, Robert K DeLong
Anticancer Research|April 30, 2016
Unique Boron Carbide Nanoparticle Nanobio Interface: Effects on Protein-RNA Interactions and 3-D Spheroid Metastatic PhenotypeRobert K Delong, Miranda N Hurst, Santosh Aryal, et al.
Plos One|December 16, 2020
Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interferenceElza Neelima Mathew, Miranda N Hurst, Baolin Wang, et al.
Molecular Pharmaceutics|January 31, 2017
Zinc Oxide Nanoparticle-Poly I:C RNA Complexes: Implication as Therapeutics against Experimental MelanomaMeghana Ramani, Miranda C Mudge, R Tyler Morris, et al.
Journal of Biomedical Nanotechnology|January 30, 2018
Enzyme and Cancer Cell Selectivity of Nanoparticles: Inhibition of 3D Metastatic Phenotype and Experimental Melanoma by Zinc OxideRobert K DeLong, Jennifer A Mitchell, R Tyler Morris, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|September 15, 2016
Two-Dimensional Fluorescence Difference Spectroscopy to Characterize Nanoparticles and their InteractionsMiranda N Hurst, Robert K DeLong
Anticancer Research|April 30, 2016
Unique Boron Carbide Nanoparticle Nanobio Interface: Effects on Protein-RNA Interactions and 3-D Spheroid Metastatic PhenotypeRobert K Delong, Miranda N Hurst, Santosh Aryal, et al.
Plos One|December 16, 2020
Interaction of Ras Binding Domain (RBD) by chemotherapeutic zinc oxide nanoparticles: Progress towards RAS pathway protein interferenceElza Neelima Mathew, Miranda N Hurst, Baolin Wang, et al.
Molecular Pharmaceutics|January 31, 2017
Zinc Oxide Nanoparticle-Poly I:C RNA Complexes: Implication as Therapeutics against Experimental MelanomaMeghana Ramani, Miranda C Mudge, R Tyler Morris, et al.
Journal of Biomedical Nanotechnology|January 30, 2018
Enzyme and Cancer Cell Selectivity of Nanoparticles: Inhibition of 3D Metastatic Phenotype and Experimental Melanoma by Zinc OxideRobert K DeLong, Jennifer A Mitchell, R Tyler Morris, et al.
Pageof 1